Alexandra Balcom, Chief Financial Officer at Nuvalent, Inc. (NUVL), sold 25,130 shares at $95.03 ($2.5M) on 2026-03-24, disclosed to the SEC on 2026-03-26.
Scheduled sale ($2.5M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $95.03 | 2,599 | $247K | 10.0% |
| 2 | $95.88 | 7,671 | $735K | 29.8% |
| 3 | $96.50 | 1,160 | $112K | 4.5% |
| 4 | $100.16 | 13,700 | $1.4M | 55.6% |
| Total | $98.15 avg | 25,130 | $2.5M | 100% |
| Filing → |
| NUVL | SELL | 2026-05-05 | $1.1M | — | Filing → |
| NUVL | SELL | 2026-04-03 | $1.2M | — | Filing → |
| NUVL | SELL | 2026-01-07 | $721K | — | Filing → |